Categories Analysis, Technology

Apple could get hurt in the fight against Huawei

The trade war between the US and China is raging on, and amid this, the US blacklisted a prominent Chinese firm, Huawei Technologies Co. Ltd, last week. Even though the US government has provided some temporary relief, the move has sparked outrage in China.

Now it appears this outrage might have a casualty in the form of Apple Inc. (NASDAQ: AAPL). Huawei has been getting plenty of support from Chinese users on social media with many declaring that they would ditch iPhones in favor of Huawei’s products.

While social media sentiment has a minor role to play in the field of hard-core business, a report by Bloomberg states that if China were to respond to the US with a similar ban on Apple’s products, it would hurt the tech giant’s earnings by 29%.

Earlier this month, a study by IDC showed that during the first quarter of 2019, Huawei surpassed Apple both on smartphone shipment volumes and market share. Huawei held a market share of 19% while Apple had only 11.7%. Huawei managed to grow its shipment volumes by 50% year-over-year while Apple’s shipments fell 30%.

Smartphone shipments and volume for Apple, Huawei, Samsung and Xiaomi

In its second-quarter 2019 earnings announcement, Apple said its sales declined 22% year-over-year in Greater China. China is Apple’s third largest market after the Americas and Europe and accounts for a meaningful portion of its revenue.

Apple already faces tough competition in China from Huawei and other local companies and the ongoing spat is likely to worsen the situation for the iPhone-maker in the region.

Apple’s shares were down 1.7% in afternoon hours on Wednesday.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top